Gene Therapy R&D and Revenue Forecasts 2017-2027: Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases

Gene Therapy R&D and Revenue Forecasts 2017-2027: Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases
LONDON, UK. August 2017 : Visiongain’ has launched a new pharma report Gene Therapy R&D and Revenue Forecasts 2017-2027: Cancer, Cardiovascular, Rare Diseases, Ophthalmologic, Other Diseases. The gene therapy market is still establishing itself and many opportunities are available to explore at the moment. One opportunity in this market is for smaller biotechnology companies, which because ...

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027: Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027: Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine
LONDON, UK. 31st July 2017: Visiongain has launched a new pharma report Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027: Analysis and Forecasts for Mammalian Cell Cultures, Microbial Fermentations, Other Expression Systems, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines and Geography The pharmaceutical industry is one of the largest and most consistent markets ...

Global Diabetes Drugs Market 2017-2027: Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others

Global Diabetes Drugs Market 2017-2027: Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others
LONDON, UK. July 2017: Visiongain’ has launched a new pharma report Global Diabetes Drugs Market 2017-2027: Insulin and Insulin Analogues, DPP-4 Inhibitors, Biguanides, GLP-1 Agonists, Alpha-glucosidases, SGLT-2 Inhibitors, Sulfonylureas and Others The IDF (International Diabetes Federation) predicts that by 2035, the global number of diabetics will reach over 582 million. While the market associated with type 1 ...

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA
Visiongain’ has launched a new pharma report Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA. With patent expiries of blockbuster drugs, the generic drugs industry grows more important to the overall pharmaceutical market. Big Pharma are now realising the potential of generics to become a ...

Revenue Prospects by Type, Application, End-User and Geography

Revenue Prospects by Type, Application, End-User and Geography
LONDON, UK. 25th July 2017: Visiongain’s new report World Bio-MEMS & Microfluidics Market Forecasts 2017-2027: Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography indicates that the global Bio-MEMS & Microfluidics market will ...

Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others

Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others
Visiongain’s new report Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others report indicates that the global drug of abuse testing market will see $5.9bn in spending in 2022. ...

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations Market Forecast 2017-2027 North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations Market Forecast 2017-2027 North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing
LONDON, UK July 2017: Visiongain’s new report Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Forecast 2017-2027 North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing report indicates that the Global Pharma CMOs Market will see $105.3bn in spending in 2021. The global pharmaceutical contract ...

Macular Degeneration & Diabetic Retinopathy Market Forecast 2017-2027: Outlook & Analysis for Ophthalmic Drugs for Other Retinal Diseases Including Age-Related Macular Degeneration, Dry AMD, Wet AMD, Diabetic Macular Edema, Retinal Vein Occlusion & Geographic Atrophy

Macular Degeneration & Diabetic Retinopathy Market Forecast 2017-2027: Outlook & Analysis for Ophthalmic Drugs for Other Retinal Diseases Including Age-Related Macular Degeneration, Dry AMD, Wet AMD, Diabetic Macular Edema, Retinal Vein Occlusion & Geographic Atrophy
A new report by visiongain forecasts the overall world market for treating age-related macular degeneration (AMD or ARMD), diabetic retinopathy (DR) and other disorders of the retina will reach $11.98bn in 2017. That revenue forecast and others appear in Macular Degeneration (AMD) & Diabetic Retinopathy (DR) Market Forecast 2017-2027: Outlook & Analysis for Ophthalmic Drugs ...

Global Women’s Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome

LONDON, UK July 2017: Visiongain’s new report Global Women’s Healthcare Market Forecast 2017-2027: Postmenopausal Osteoporosis, Hormonal Contraceptives, Menopause, Infertility, Endometriosis, Polycystic Ovary Syndrome indicates that the global women’s healthcare market will see $37.5bn in spending in 2021. The revenue of the women’s healthcare market in 2016 is estimated at $31.1bn and is expected to grow ...

Antithrombotic Drugs Market 2017 – 2027: Anticoagulants, Antiplatelets, Fibrinolytics

Antithrombotic Drugs Market 2017 – 2027: Anticoagulants, Antiplatelets, Fibrinolytics
LONDON, UK July 2017: Visiongain’s new report Antithrombotic Drugs Market 2017 – 2027: Anticoagulants, Antiplatelets, Fibrinolytics indicates that the antithrombotic drugs market will see $26.4bn in spending in 2021. The revenue of the antithrombotic drugs market in 2016 is estimated at $18.08bn and is expected to grow at a CAGR of 7.9% in the first ...